Precision BioSciences is developing mulitple DNE therapeutics targeted to enable the precise in situ correction of genes responsible for human disease.
More about BioTherapeutics
Engineered DNE meganucleases are being used to engineer cell lines for disease models or optimize cell lines for the biomanufacturing of protein vaccines and therapeutics.
More about BioTools
Custom DNE meganucleases produced by Precision BioSciences enable site-specific engineering of row crops and biofuel feedstocks.
More about PlantSciences
Recent News:
04.25.2012
Precision BioSciences Files Tenth Patent Infringement Lawsuit Against Cellectis
02.23.2012
Precision BioSciences Announces Allowance of Five Additional U.S. Patent Applications
Featured Publication:
04.06.2010
Precision BioSciences and DuPont Detail Technology Efficacy in The Plant Journal
